National Path Lab

Diabetes & Metabolic Risk

Kidney disease risk refers to the likelihood of developing reduced kidney function or kidney damage over time. The kidneys perform essential functions — filtering waste, balancing fluids and electrolytes, and regulating blood pressure — and can lose significant function before any symptom appears.

Chronic kidney disease is often called a silent condition for this reason: by the time symptoms such as swelling or fatigue develop, substantial kidney function may already have been lost.

At National Path Lab (NPL), kidney function and urine testing is available to support early risk detection, particularly for individuals with diabetes, hypertension, or other recognized risk factors.

Tests Available at NPL

GLYCOSYLATED HEMOGLOBIN; HBA1C

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 1000

View DetailBook Now

LIPID PROFILE.

Turn Around Time
same day

Rs. 1000

View DetailBook Now

INSULIN, FASTING

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 1800

View DetailBook Now

About Diabetes & Metabolic Risk

Who Is at Risk?

Diabetes and metabolic risk depend on a combination of inherited and lifestyle factors:

Non-Modifiable Factors

Modifiable factors

  • Family history of diabetes

  • Obesity, particularly abdominal obesity

  • Age (risk increases with age, particularly after 45)

  • Sedentary lifestyle and physical inactivity

  • Ethnicity — some populations carry higher baseline risk

  • Diet high in refined carbohydrates and sugar

  • Personal history of gestational diabetes

  • Hypertension

  • Polycystic ovary syndrome (PCOS)

  • Smoking

Warning Signs You Shouldn't Ignore

•  Increased thirst and frequent urination

•  Unexplained weight loss or, less specifically, weight gain

•  Fatigue

•  Blurred vision

•  Slow-healing wounds

•  Recurrent infections

•  Darkened skin patches, particularly around the neck or armpits (acanthosis nigricans, associated with insulin resistance)

Test

Clinical Relevance

HbA1c

Reflects average blood glucose over the previous 2–3 months; a practical, non-fasting screening test.

Fasting Plasma Glucose (FPG)

Measures blood glucose after an overnight fast.

Oral Glucose Tolerance Test (OGTT)

Used in specific higher-risk or unclear situations.

Lipid Profile

Assesses the cardiovascular risk that commonly accompanies metabolic risk.

Urine Albumin-to-Creatinine Ratio (ACR)

Screens for early kidney involvement, particularly relevant once diabetes is present.

Fasting Insulin

May be used in selected cases to further assess insulin resistance.

Related Packages

DIABETES SCREENING PACKAGE

Test Includes
12 Tests

Rs. 3500

View DetailBook Now

Frequently Asked Questions

HbA1c and fasting plasma glucose are the most commonly used first-line tests, with OGTT reserved for specific situations where diagnosis remains unclear.
No — this is one of its practical advantages, which is why it's often used for convenient risk screening.
Yes, in many cases. Lifestyle changes — weight management, increased activity, dietary changes — can reverse prediabetes or significantly delay progression to diabetes, particularly when identified early.
Because diabetes is a leading cause of chronic kidney disease, and urine ACR can detect early kidney involvement before it would be apparent through symptoms alone.
Yes, if you have risk factors. Prediabetes and early diabetes are typically silent, which is exactly why risk-based screening — not waiting for symptoms — is recommended.